ERBB2 and cancer: Similar patterns were noted in HR + HER2- disease where PIK3CA and GATA3 (p = 0.03) and ESR1 and TP53 (p = 0.002) tend to be mutually exclusive, suggesting distinct mechanisms of endocrine resistance in TP53 mutant cancer.